Regeneron Pharmaceuticals Inc. buy Canaccord Genuity Group Inc.
Start price
21.08.23
/
50%
€762.50
Target price
21.08.24
€910.85
Performance (%)
39.08%
End price
22.08.24
€1,060.5
Summary
This prediction ended on 22.08.24 with a price of €1,060.5. With a performance of 39.08% the BUY prediction by Canaccord_Genuity_Gr was a big success. Canaccord_Genuity_Gr has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Canaccord_Genuity_Gr has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -2.342% | -2.342% | 13.774% |
| iShares Core DAX® | -2.796% | -1.396% | -0.221% |
| iShares Nasdaq 100 | -6.352% | -0.407% | 28.998% |
| iShares Nikkei 225® | -6.943% | -0.275% | 48.214% |
| iShares S&P 500 | -3.410% | 0.396% | 20.281% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $992.00 price target on the stock, up previously from $720.00.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by Canaccord_Genuity_Gr for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€539.80
19.05.26
19.05.26
€751.63
19.05.27
19.05.27
-1.10%
16:19
16:19
